PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

74 hedge funds and large institutions have $53.2M invested in Invesco Biotechnology & Genome ETF in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
22
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PSF
Pacific Sun Financial
California
+$639K
2
Jane Street
Jane Street
New York
+$377K
3
HighTower Advisors
HighTower Advisors
Illinois
+$302K
4
Morgan Stanley
Morgan Stanley
New York
+$298K
5
BRWA
B. Riley Wealth Advisors
Florida
+$205K

Top Sellers

1
VF
Virtu Financial
New York
-$1.47M
2
Wells Fargo
Wells Fargo
California
-$333K
3
TAM
Trillium Asset Management
Massachusetts
-$320K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$228K
5
Bank of America
Bank of America
North Carolina
-$225K
Name Holding Trade Value Shares
Change 		Shares
Change %
FAAS
76
First Allied Advisory Services
California
– -$24K -531 Closed
KJWM
77
Kiley Juergens Wealth Management
Washington
– -$14K -300 Closed
HWM
78
Holloway Wealth Management
Florida
– -$9K – –
1 2 3
4